Understanding the role of antibiotic-associated adverse events in influencing antibiotic decision-making
Antimicrobial Stewardship & Healthcare Epidemiology · 2024 · 4 (1)
DOI: 10.1017/ash.2024.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 30.01.2024. Verfasst von Jerald P Cherian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCEZID CDC HHS.
Themen: Patientensicherheit
Abstract (Originalsprache)
Objective
To (1) understand the role of antibiotic-associated adverse events (ABX-AEs) on antibiotic decision-making, (2) understand clinician preferences for ABX-AE feedback, and (3) identify ABX-AEs of greatest clinical concern.
Design
Focus groups.
Setting
Academic medical center.
Participants
Medical and surgical house staff, attending physicians, and advanced practice practitioners.
Methods
Focus groups were conducted from May 2022 to December 2022. Participants discussed the role of ABX-AEs in antibiotic decision-making and feedback preferences and evaluated the prespecified categorization of ABX-AEs based on degree of clinical concern. Thematic analysis was conducted using inductive coding.
Results
Four focus groups were conducted ( n = 15). Six themes were identified. (1) ABX-AE risks during initial prescribing influence the antibiotic prescribed rather than the decision of whether to prescribe. (2) The occurrence of an ABX-AE leads to reassessment of the clinical indication for antibiotic therapy. (3) The impact of an ABX-AE on other management decisions is as important as the direct harm of the ABX-AE. (4) ABX-AEs may be overlooked because of limited feedback regarding the occurrence of ABX-AEs. (5) Clinicians are receptive to feedback regarding ABX-AEs but are concerned about it being punitive. (6) Feedback must be curated to prevent clinicians from being overwhelmed with data. Clinicians generally agreed with the prespecified categorizations of ABX-AEs by degree of clinical concern.
Conclusions
The themes identified and assessment of ABX-AEs of greatest clinical concern may inform antibiotic stewardship initiatives that incorporate reporting of ABX-AEs as a strategy to reduce unnecessary antibiotic use.
Autor:innen und Institutionen
- Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- Department of Pediatrics, Center for Child and Community Health Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- Department of Pediatrics, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
ORCID-Profile: Jerald P Cherian, Alejandra Salinas, Suzanne M Grieb, Eili Y Klein
Förderung
- NCEZID CDC HHS
Zitieren
APA
Cherian, J. P., Helsel, T. N., Jones, G. F., Virk, Z., Salinas, A., Grieb, S. M., Klein, E. Y., Tamma, P. D., Cosgrove, S. E., & Centers for Disease Control and Prevention’s Prevention Epicenters Program (2024). Understanding the role of antibiotic-associated adverse events in influencing antibiotic decision-making. Antimicrobial Stewardship & Healthcare Epidemiology, 4(1). https://doi.org/10.1017/ash.2024.2
Vancouver
Cherian JP, Helsel TN, Jones GF, Virk Z, Salinas A, Grieb SM, et al. Understanding the role of antibiotic-associated adverse events in influencing antibiotic decision-making. Antimicrobial Stewardship & Healthcare Epidemiology. 2024;4(1). doi:10.1017/ash.2024.2
BibTeX
@article{Cherian2024,
author = {Cherian, Jerald P and Helsel, Taylor N and Jones, George F and Virk, Zunaira and Salinas, Alejandra and Grieb, Suzanne M and Klein, Eili Y and Tamma, Pranita D and Cosgrove, Sara E and Centers for Disease Control and Prevention’s Prevention Epicenters Program, Centers for Disease Control and Prevention’s Prevention Epicenters Program},
title = {Understanding the role of antibiotic-associated adverse events in influencing antibiotic decision-making},
journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
year = {2024},
volume = {4},
number = {1},
doi = {10.1017/ash.2024.2}
}
EUVIMED